Differential Proinflammatory Signature in Vestibular Migraine and Meniere Disease
Identificadores
Identificadores
Visualización o descarga de ficheros
Visualización o descarga de ficheros
Fecha de publicación
2019Título de revista
Frontiers in Immunology
Tipo de contenido
Artigo
DeCS
estudios de casos y controles | anciano | evaluación de síntomas | diagnóstico | mediana edad | humanos | área bajo la curva | leucocitos | adulto | perfiles de expresión génica | susceptibilidad a enfermedades | redes génicas reguladorasMeSH
Adult | Middle Aged | Humans | Area Under Curve | Disease Susceptibility | Diagnosis | Leukocytes | Gene Expression Profiling | Case-Control Studies | Symptom Assessment | Aged | Gene Regulatory NetworksResumen
Vestibular Migraine (VM) and Meniere's Disease (MD) are episodic vestibular syndromes defined by a set of associated symptoms such as tinnitus, hearing loss or migraine features during the attacks. Both conditions may show symptom overlap and there is no biological marker to distinguish them. Two subgroups of MD patients have been reported, according to their IL-1beta profile. Therefore, considering the clinical similarity between VM and MD, we aimed to investigate the cytokine profile of MD and VM as a means to distinguish these patients. We have also carried out gene expression microarrays and measured the levels of 14 cytokines and 11 chemokines in 129 MD patients, 82 VM patients, and 66 healthy controls. Gene expression profile in peripheral blood mononuclear cells (PBMC) showed significant differences in MD patients with high and low basal levels of IL- 1beta and VM patients. MD patients with high basal levels of IL- 1beta (MDH) had overall higher levels of cytokines/chemokines when compared to the other subsets. CCL4 levels were significantly different between MDH, MD with low basal levels of IL- 1beta (MDL), VM and controls. Logistic regression identified IL- 1beta, CCL3, CCL22, and CXCL1 levels as capable of differentiating VM patients from MD patients (area under the curve = 0.995), suggesting a high diagnostic value in patients with symptoms overlap.